PMC:7243768 / 4644-4809 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"148","span":{"begin":107,"end":111},"obj":"Gene"},{"id":"184","span":{"begin":48,"end":56},"obj":"Disease"},{"id":"185","span":{"begin":57,"end":66},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"tao:has_database_id","subj":"148","obj":"Gene:59272"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"MESH:C000657245"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-increasing drugs are at higher risk for severe COVID-19 infection and, therefore, should be monitored for ACE2-modulating medications, such as angiotensin-convertin"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T61","span":{"begin":48,"end":56},"obj":"Disease"},{"id":"T62","span":{"begin":57,"end":66},"obj":"Disease"}],"attributes":[{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"-increasing drugs are at higher risk for severe COVID-19 infection and, therefore, should be monitored for ACE2-modulating medications, such as angiotensin-convertin"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":12,"end":17},"obj":"Chemical"},{"id":"T13","span":{"begin":144,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"-increasing drugs are at higher risk for severe COVID-19 infection and, therefore, should be monitored for ACE2-modulating medications, such as angiotensin-convertin"}